Sodium intake and renal outcomes: A systematic review

American Journal of Hypertension

Volumn 27, Issue 10, 2014, Pages 1277-1284

  Smyth, Andrew ^a,b,c   O'Donnell, Martin J ^b,c   Yusuf, Salim ^c   Clase, Catherine M ^d   Teo, Koon K ^c   Canavan, Michelle ^b   Reddan, Donal N ^a   Mann, Johannes F E ^c,e,f  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c MCMASTER UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f Munich General Hospital   (Germany)

Author keywords

Blood pressure; Chronic kidney disease; Clinical epidemiology; Hypertension; Nutrition

Indexed keywords

CREATININE; SODIUM INTAKE;

ADVERSE OUTCOME; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIALYSIS; HUMAN; KIDNEY FUNCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RETROSPECTIVE STUDY; REVIEW; SODIUM EXCRETION; SODIUM INTAKE; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; UTILIZATION;

HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; PROTEINURIA; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SODIUM, DIETARY;

EID: 84914687289     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt294     Document Type: Review

References (40)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047.
2. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H. The burden of kidney disease: improving global outcomes. Kidney International 2004; 66:1310-1314.
3. Morgan T, Adam W, Gillies A, Wilson M, Morgan G, Carney S. Hypertension treated by salt restriction. Lancet 1978; 1:227-230.
4. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH, Jr., Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998; 279:839-846.
5. Kidney Disease Outcomes Quality I. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. American Journal Kidney Diseases 2004; 43(5 Suppl 1):S1-290.
6. European Guidelines for the Nutritional Care of Adult Renal Patients. Dietitians Special Interest Group. European Dialysis and Transplantation Nurses Association/European Renal Care Association. http://www. eesc.europa.eu/self-and-coregulation/documents/codes/private/086-private-act.pdf. 2002. Accessed 13 January 2014.
7. Sodium in pre-dialysis patients. Caring for Australasians with Renal Impairment. http://www.cari.org.au/CKD-nutrition/CKD-nutrition-list-published/sodium-in-pre-dialysis. 2005. Accessed 13 January 2014.
8. Dietary Guidelines for Americans. U.S. Department of Agriculture & U.S. Department of Health and Human Services. http://www. health.gov/dietaryguidelines/dga2010/DietaryGuidelines2010.pdf. 2010. Accessed 13 January 2014.
9. Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals Internal Medicine 2013; 158:825-830.
10. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurraw S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M, Canadian Society of Nephrology. Guidelines for the management of chronic kidney disease. CMAJ 2008; 179:1154-1162.
11. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation 2012; 126:2880-2889.
12. Royal College of Physicians. Chronic kidney disease in adults: UK guidelines for identification, management and referral. London, RCP, 2005. http://www.rcplondon.ac.uk.
13. Jones-Burton C, Mishra SI, Fink JC, Brown J, Gossa W, Bakris GL, Weir MR. An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. American Journal Nephrology 2006; 26:268-275.
14. O'Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011; 306:2229-2238.
15. Dong J, Li Y, Yang Z, Luo J. Low dietary sodium intake increases the death risk in peritoneal dialysis. Clinical Journal American Society of Nephrology 2010; 5:240-247.
16. National Research Council. Sodium Intake in Populations: Assessment of Evidence. Washington, DC: The National Academies Press, 2013.
17. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical-epidemiology/oxford. asp. Accessed 13 January 2014.
18. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods G, Cochrane Statistical Methods G. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343:d5928.
19. Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, De Nicola L. Salt intake and renal outcome in patients with progressive renal disease. Mineral Electrolyte Metabolism 1998; 24:296-301.
20. Amaha M, Ohashi Y, Sakai K, Aikawa A, Mizuiri S. [Salt intake and the progression of renal failure in patients with chronic kidney disease]. Nihon Jinzo Gakkai Shi 2010; 52:952-958.
21. Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. Journal American Society Nephrology 2012; 23:165-173.
22. Lin J, Hu FB, Curhan GC. Associations of diet with albuminuria and kidney function decline. Clinical Journal American Society Nephrology 2010; 5:836-843.
23. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Waden J, Tolonen N, Saraheimo M, Gordin D, Groop PH, FinnDiane Study G. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011; 34:861-866.
24. Lambers Heerspink HJ, Holtkamp FA, Parving HH, Navis GJ, Lewis JB, Ritz E, de Graeff PA, de Zeeuw D. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney International 2012; 82:330-337.
25. He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, MacGregor GA. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 2009; 54:482-488.
26. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease HBPRCC, Epidemiology, Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42:1050-1065.
27. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Hale RE, Campbell KL. The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial. BMC Nephrology 2012; 13:137.
28. Saran R, Sands RL, Gillespie BW, Heung M, Hummel SL, Darebail VK, Pitt B, Levin NW, Zhu F, Kotanko P, Klemmer PJ. A Crossover Trial of Lowering Dietary Sodium (Na) in Chronic Kidney Disease.: ASN Kidney Week 2012, San Diego, CA, USA, 2012.
29. Takachi R, Inoue M, Shimazu T, Sasazuki S, Ishihara J, Sawada N, Yamaji T, Iwasaki M, Iso H, Tsubono Y, Tsugane S, Japan Public Health Center-based Prospective Study G. Consumption of sodium and salted foods in relation to cancer and cardiovascular disease: the Japan Public Health Center-based Prospective Study. American Journal Clinical Nutrition 2010; 91:456-464.
30. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ 1997; 315:722-729.
31. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA 1992; 267:1213-1220.
32. Wright JT, Jr., Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG, African American Study of Kidney D, Hypertension Study G. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288:2421-2431.
33. Berl T. Review: renal protection by inhibition of the renin-angiotensin-aldosterone system. Journal Renin-Angiotensin-Aldosterone System 2009; 10:1-8.
34. Yoshioka T, Rennke HG, Salant DJ, Deen WM, Ichikawa I. Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis. Circulation Research 1987; 61:531-538.
35. Fukuda M, Kimura G. Salt sensitivity and nondippers in chronic kidney disease. Current Hypertension Reports 2012; 14:382-387.
36. Luft FC, Fineberg NS, Sloan RS. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension 1982; 4:805-808.
37. Rakova N, Juttner K, Dahlmann A, Schroder A, Linz P, Kopp C, Rauh M, Goller U, Beck L, Agureev A, Vassilieva G, Lenkova L, Johannes B, Wabel P, Moissl U, Vienken J, Gerzer R, Eckardt KU, Muller DN, Kirsch K, Morukov B, Luft FC, Titze J. Long-term space flight simulation reveals infradian rhythmicity in human Na(+) balance. Cell Metabolism 2013; 17:125-131.
38. Paterna S, Fasullo S, Parrinello G, Cannizzaro S, Basile I, Vitrano G, Terrazzino G, Maringhini G, Ganci F, Scalzo S, Sarullo FM, Cice G, Di Pasquale P. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). American Journal Medical Sciences 2011; 342:27-37.
39. Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. American Journal Cardiology 2009; 103:93-102.
40. Retraction. Low sodium versus normal sodium diets in systolic heart failure: systematic review and meta-analysis. Heart. Published Online First: 21 August 2012 doi:10.1136/heartjnl-2012-302337. Heart 2013; 99:820.